Rovin Capital Bio Rad Laboratories, Inc. Transaction History
Rovin Capital
- $278 Million
- Q4 2024
A detailed history of Rovin Capital transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Rovin Capital holds 1,667 shares of BIO stock, worth $397,046. This represents 0.2% of its overall portfolio holdings.
Number of Shares
1,667
Previous 1,999
16.61%
Holding current value
$397,046
Previous $669,000
18.09%
% of portfolio
0.2%
Previous 0.25%
Shares
2 transactions
Others Institutions Holding BIO
# of Institutions
477Shares Held
18.2MCall Options Held
15.7KPut Options Held
11.5K-
Vanguard Group Inc Valley Forge, PA1.92MShares$457 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$369 Million0.01% of portfolio
-
Veritas Asset Management LLP977KShares$233 Million3.36% of portfolio
-
Dimensional Fund Advisors LP Austin, TX746KShares$178 Million0.06% of portfolio
-
Van Eck Associates Corp723KShares$172 Million0.3% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $5.87B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...